Tag: Respiratory medicine

Studies have shown that salbutamol nebulization can lead to a significant, though temporary, increase in heart rate, even at low doses. This phenomenon, often experienced by patients as palpitations or tachycardia, raises the important question: **Does salbutamol increase heart rate?**

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with a median survival of just 3 to 5 years without treatment. As one of only two FDA-approved medications for this condition, pirfenidone is an antifibrotic agent that plays a critical role in slowing the decline of lung function.

By the late 1980s, theophylline generated sales of about $1 billion worldwide, but its use has since dramatically declined due to significant safety concerns and the emergence of superior treatments. This shift in medical practice directly answers the question, 'Why is theophylline no longer used?', making it a fourth-line or relegated therapy in modern respiratory care.

According to clinical trial data published in the *New England Journal of Medicine*, the combination inhaler AIRSUPRA demonstrated a significantly lower risk of severe asthma exacerbations compared to albuterol alone. So, is AIRSUPRA better than albuterol? The answer depends on a patient's specific treatment needs, as AIRSUPRA combines a bronchodilator with an anti-inflammatory corticosteroid, offering a different therapeutic approach to asthma management than albuterol alone.

Oxygen, while naturally occurring in the air we breathe, is considered a medical gas and regulated as a drug by the U.S. Food and Drug Administration (FDA) when used for medical purposes. This means that medical oxygen, unlike the air around us, requires a prescription, must meet strict purity standards, and its use must be monitored by healthcare professionals.

Over 95% of patients switching from the branded Fostair inhaler to the bioequivalent Bibecfo found no change in effectiveness or usage technique. This high degree of similarity leads many to question: what is the difference between Fostair and bibecfo? While the core medication and effect are identical, the distinction lies primarily in the brand, manufacturer, and cost.

For individuals with chronic obstructive pulmonary disease (COPD), STIOLTO Respimat provides a dual-action timeline for symptom improvement, starting as quickly as five minutes after the first dose. However, as a long-term maintenance treatment, it requires consistent daily use over several weeks to reach its maximum therapeutic benefit.

A cough is a primary defense mechanism for clearing airways [1.5.2]. But when it's a persistent dry cough, the question arises: can Levolin be given for dry cough? This article explores the appropriate use of this common medication.

Clinical studies show that formoterol provides significant bronchodilation within five minutes of administration, offering a unique dual advantage among long-acting beta2-agonists (LABAs). The advantages of formoterol stem from this rapid onset combined with its prolonged 12-hour effect, making it a cornerstone for managing respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD).

According to the American Thoracic Society, many patients have difficulty using a standard inhaler correctly, with some studies showing successful delivery rates as low as 15%. Understanding the core distinction, and how it impacts usage, is key to comprehending the difference between a Turbuhaler and inhaler types like the metered-dose inhaler (MDI).